SANTA ROSA, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced that the Company will release 2014 fourth quarter and year-end financial results after market close on Tuesday, March 3, 2015. Company management will host a conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3 to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing (844) 831-3024 for domestic callers, or (315) 625-6887 for international callers, or from the webcast on the investor relations section of the Company’s website at: www.trivascular.com. The webcast will be available on the Company’s website for two weeks following the completion of the call.
About TriVascular Technologies, Inc. - TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime® Abdominal Stent Graft System, the lowest profile FDA-approved endovascular aortic repair (EVAR) system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.
For more information visit www.trivascular.com.
CONTACT: Media Contact: Vivek K. Jayaraman VP, Global Sales & Marketing (707) 543-8804 vivek.jayaraman@trivascular.com Investor Relations Contact: Westwicke Partners Jamar Ismail (415) 513-1282 jamar.ismail@westwicke.com
Help employers find you! Check out all the jobs and post your resume.
